The Arab Drug Company (EGX:ADCI)
Egypt
· Delayed Price · Currency is EGP 178.19
-0.15 (-0.08%)
At close: Apr 28, 2026
The Arab Drug Company Cash Flow Statement
Financials in millions EGP. Fiscal year is July - June.
Millions EGP. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2020 - 2016 |
| Net Income | 256.4 | 227.86 | 102.82 | 82.77 | 76.3 | 101.41 | Upgrade
|
| Depreciation & Amortization | 25,379 | 25,361 | 3.37 | 3.26 | 9.39 | 7.81 | Upgrade
|
| Other Operating Activities | -25,412 | -25,424 | 29.58 | 1.48 | -52.82 | -72.65 | Upgrade
|
| Operating Cash Flow | 223.31 | 164.28 | 135.77 | 87.51 | 32.87 | 36.58 | Upgrade
|
| Operating Cash Flow Growth | 79.86% | 21.00% | 55.15% | 166.22% | -10.14% | -50.05% | Upgrade
|
| Capital Expenditures | -133.18 | -198.9 | -285.98 | -63.18 | -89.92 | -28.87 | Upgrade
|
| Investment in Securities | - | - | - | - | 13.88 | - | Upgrade
|
| Other Investing Activities | 8.47 | 19.27 | 27.92 | 1.07 | 1.63 | 4.34 | Upgrade
|
| Investing Cash Flow | -124.71 | -179.63 | -258.07 | -62.11 | -74.41 | -24.53 | Upgrade
|
| Short-Term Debt Issued | - | - | - | - | 27.33 | - | Upgrade
|
| Long-Term Debt Issued | - | 35.79 | 339.09 | 51.3 | 52.54 | - | Upgrade
|
| Total Debt Issued | 46.7 | 35.79 | 339.09 | 51.3 | 79.87 | - | Upgrade
|
| Long-Term Debt Repaid | - | -97.24 | -44.55 | - | - | - | Upgrade
|
| Total Debt Repaid | -89.26 | -97.24 | -44.55 | - | - | - | Upgrade
|
| Net Debt Issued (Repaid) | -42.56 | -61.46 | 294.54 | 51.3 | 79.87 | - | Upgrade
|
| Common Dividends Paid | -82.53 | -63.11 | -36.1 | -37.49 | -43.54 | -38.85 | Upgrade
|
| Other Financing Activities | -57.03 | -48.56 | -23.09 | -1.68 | -0.95 | - | Upgrade
|
| Financing Cash Flow | -182.12 | -173.12 | 235.35 | 12.13 | 35.38 | -38.85 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | 71.1 | 35.04 | 69.18 | -27.33 | - | -0 | Upgrade
|
| Net Cash Flow | -12.42 | -153.44 | 182.24 | 10.2 | -6.15 | -26.8 | Upgrade
|
| Free Cash Flow | 90.13 | -34.63 | -150.22 | 24.33 | -57.04 | 7.71 | Upgrade
|
| Free Cash Flow Growth | - | - | - | - | - | -89.09% | Upgrade
|
| Free Cash Flow Margin | 7.31% | -3.10% | -19.12% | 3.84% | -11.29% | 1.44% | Upgrade
|
| Free Cash Flow Per Share | 7.51 | -2.89 | -12.52 | 2.03 | -4.21 | 0.56 | Upgrade
|
| Cash Interest Paid | 57.03 | 48.56 | 23.09 | 1.68 | 0.95 | - | Upgrade
|
| Cash Income Tax Paid | 61.15 | 47.18 | 34.73 | 35.09 | 51.95 | 52.97 | Upgrade
|
| Levered Free Cash Flow | 25,351 | 25,184 | -184.62 | -24.95 | -121.56 | -1.96 | Upgrade
|
| Unlevered Free Cash Flow | 25,387 | 25,214 | -170.19 | -23.5 | -120.96 | -1.93 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.